Precision Medicine News and Research

RSS

Researchers identify a signature of three genes linked to positive response to blood cancer therapy

Mount Sinai researchers have for the first time identified genes that predict a good response to a vital new therapy for a blood cancer that can have serious side effects for some patients.

16 Jun 2022

Scientists publish a robust framework to analyze chromosomal instability in human cancers

Scientists have found a way to identify and interpret 'signatures' that reveal the complex genetic causes of some of the deadliest cancers – which often have a survival rate of less than 10%.

15 Jun 2022

Prostate cancer treatment guidelines need to be updated, research suggests

Current guidelines used to plan salvage radiation treatments in patients with local recurrence of prostate cancer should be updated to take into consideration information derived from novel imaging modalities, such as PSMA PET, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting.

15 Jun 2022

Study shows alarming trends in mortality from alcoholic cirrhosis in the U.S.

Alcoholic cirrhosis is an advanced form of alcohol-related liver disease. In the United States between 2010 and 2016, alcohol-related liver disease was the primary cause of nearly 1 in 3 liver transplants, surpassing hepatitis C.

14 Jun 2022

Nanomaterial-based devices may be a viable option for monitoring, treatment of cardiovascular diseases

Cardiovascular diseases are the leading cause of death across the globe, responsible for about 17.9 million (32%) of all deaths worldwide every year.

10 Jun 2022

Genetic testing results in lower length of stay in the NICU for infants with epilepsy

Genetic testing results in lower length of stay in the neonatal intensive care unit (NICU) for infants with epilepsy, according to a study published in the journal Pediatric Neurology.

7 Jun 2022

$New combination of drugs increases survival time for some patients with refractory lung cancer$

New combination of drugs increases survival time for some patients with refractory lung cancer

A combination of the drugs ramucirumab and pembrolizumab reduced risk of death by 31% compared with the standard of care in patients with advanced non-small cell lung cancer that had progressed on prior immunotherapy.

3 Jun 2022

Lack of diversity in genomic research could deprive Africans of life-changing care for chronic diseases

The lack of diversity in genomic research could mean Africans are missing out on potential life-changing care for chronic health disorders, according to a new study published in Nature Medicine.

3 Jun 2022

Study: Pulse oximeter devices overestimated blood oxygen levels in non-White patients with COVID-19

A retrospective analysis of over 7,000 patients with COVID-19 found that pulse oximeter devices — tools that measure oxygen levels in the blood and that are used in virtually every U.S. hospital — overestimated blood oxygen levels in non-White patients.

31 May 2022

UK and Sweden commit to enhance co-operation in the life sciences

Today (27 May 2022), Parliamentary Under-Secretary of State for Innovation at the Department of Health and Social Care, Lord Kamall, and the Swedish Minister for Education, Anna Ekström, signed a Memorandum of Understanding (MoU) committing the UK and Sweden to ongoing co-operation in the life sciences.

27 May 2022

Discovery of new prostate cancer subtype opens the door to development of therapies

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.

27 May 2022

FAU team receives $1 million grant to identify effective fall prevention strategies for older adults

Every second, an older person in the United States falls and injures themselves, and every 20 minutes one of them dies from the fall. More than 30 percent of adults 65 and older fall every year and 25 percent of them have moderate to severe injuries.

26 May 2022

Scientists discover a gene defect that results in allergic and autoimmune disease

Inflammation of the skin and the esophagus, food allergy and asthma are just some of the symptoms of a now 12-year-old boy who was the first to have a mutation on the IL-33 gene. An international team led by a physician from the Karl Landsteiner University for Health Sciences, Krems, discovered this new disease entity.

26 May 2022

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

The accelerated advancement of cancer immunology and immunotherapy, a type of biological therapy that boosts the immune system's ability to recognize and kill cancer cells, has significantly improved the effectiveness of cancer treatment and patient outcomes.

25 May 2022

Study brings precision medicine closer to reality for diffuse large B cell lymphoma

DNA mutations are essential to the rapid development of an array of antibody-producing immune cells called B cells that collectively can recognize a vast number of specific targets.

25 May 2022

AI model can accurately identify patients at high risk of undiagnosed structural heart disease

A team of clinicians and scientists from Tempus and Geisinger have found that a new artificial intelligence model can accurately identify patients at increased risk of undiagnosed structural heart disease.

25 May 2022

A digital twin for your immune system

In a recent study posted to the NPJ Digital Medicine journal, researchers illustrated a framework for constructing digital twins of the human immune system.

23 May 2022

A step-by-step plan to create a digital twin of the human immune system

An article published May 20 in Nature Digital Medicine provides a step-by-step plan for an international effort to create a digital twin of the human immune system.

20 May 2022

Molecular profiling of diseased joints could transform treatment for rheumatoid arthritis patients

New research from Queen Mary University of London, published in Nature Medicine, has shown that molecular profiling of the diseased joint tissue can significantly impact whether specific drug treatments will work to treat rheumatoid arthritis (RA) patients.

19 May 2022

Intestinal microbiome may contribute to the pathogenesis of MSI colon cancers, study suggests

Investigators from Rutgers Cancer Institute of New Jersey, New Jersey's only National Cancer Institute- Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including microsatellite-stable and unstable (MSI) tumors.

19 May 2022

Precision Medicine News and Research

Researchers identify a signature of three genes linked to positive response to blood cancer therapy

Scientists publish a robust framework to analyze chromosomal instability in human cancers

Prostate cancer treatment guidelines need to be updated, research suggests

Study shows alarming trends in mortality from alcoholic cirrhosis in the U.S.

Nanomaterial-based devices may be a viable option for monitoring, treatment of cardiovascular diseases

Genetic testing results in lower length of stay in the NICU for infants with epilepsy

New combination of drugs increases survival time for some patients with refractory lung cancer

Lack of diversity in genomic research could deprive Africans of life-changing care for chronic diseases

Study: Pulse oximeter devices overestimated blood oxygen levels in non-White patients with COVID-19

UK and Sweden commit to enhance co-operation in the life sciences

Discovery of new prostate cancer subtype opens the door to development of therapies

FAU team receives $1 million grant to identify effective fall prevention strategies for older adults

Scientists discover a gene defect that results in allergic and autoimmune disease

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

Study brings precision medicine closer to reality for diffuse large B cell lymphoma

AI model can accurately identify patients at high risk of undiagnosed structural heart disease

A digital twin for your immune system

A step-by-step plan to create a digital twin of the human immune system

Molecular profiling of diseased joints could transform treatment for rheumatoid arthritis patients

Intestinal microbiome may contribute to the pathogenesis of MSI colon cancers, study suggests

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News